We supported a company looking to embark on a transformative journey and build capabilities for biosimilars manufacturing. We conducted an evidence-based analysis of a potential project, focusing on the project's strategic importance, the gap in demand and availability, commercial market dynamics, necessary investment costs, project timelines, and skills requirements

A medical company in the in vitro diagnostics space was falling short of its supply chain and procurement functions. We worked across the organisation—strategy, R&D, and supply chain to drive operational improvements by building forecasting capabilities, adding agility, and optimising the quality and cost of consumables

We worked with a new investment fund to create a strategy for a premier launch event. Aiming to prepare an exciting agenda, we conducted market research with investors, entrepreneurs, and academia to assess the attractiveness and feasibility of elevating emerging research areas during the event.

We performed an annual sustainability review of a laboratory service provider for food and pharmaceutical analysis to monitor the implementation of key ESG initiatives along the Sustainable Development Goals matrix and beyond

A pharma company sought to develop a payer engagement strategy for late-stage assets targeting a rare liver disease. The company aimed to develop measures for interacting with payers and payer advisory stakeholders to advance the field before launch and formulate an engagement plan accordingly

We worked with senior pharma executives to ensure launch support of a drug in the immunology space. By creating an understanding of an asset’s clinical profile and competitive positioning, we refined strategic communication materials to demonstrate its value to all stakeholders in the HTA assessment and the pricing and reimbursement process.